Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06057038 2026-03-03

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Phase 1 Active not recruiting

42 enrolled

Other solid neoplasm

Malignant Solid Tumor

NCT06994806 2026-03-03

A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Phase 1 Recruiting

84 enrolled

Other solid neoplasm

Solid Tumor Malignancies

NCT05083481 2026-02-27

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Phase 1/2 Recruiting

366 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07204340 2026-02-27

TLN-372 in Advanced KRAS Mutant Solid Tumors

Phase 1 Recruiting

240 enrolled

Other solid neoplasm

KRAS Mutant Solid Tumors

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

197 enrolled

Other solid neoplasm

Solid Tumor, Adult

Clinical Trials

aCCeleR8-001

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

KEYNOTE-603

RAINFOL-01

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

TLN-372 in Advanced KRAS Mutant Solid Tumors

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors